tonefotografia /
3 November 2016Americas

Onyx Therapeutics sues Dr Reddy’s for patent infringement

US-based Onyx Therapeutics has filed a complaint against India company Dr Reddy’s Laboratories for allegedly infringing a patent covering the drug Kyprolis (carfilzomib).

Kyprolis is a treatment for relapsed or refractory multiple myeloma, which is a type of cancer.

The case, which was filed on Tuesday, November 1 in the US District Court for the District of Delaware, arose after Dr Reddy’s filed an Abbreviated New Drug Application with the Food and Drug Administration seeking approval to manufacture a generic version of the drug.

The patent involved in the case is US number 7,737,112.

Onyx has asked the court for a declaration that Dr Reddy’s has infringed its patent.

The company has also asked the court to award it costs and expenses for bringing the case to court.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at